Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized nonsmall cell lung cancer (NSCLC) treatment and significantly increased overall survival of patients. However, the incidence of concurrent infections and their management is still debated. METHODS: From August 2015 to October 2019,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Forum Infect Dis
Asıl Yazarlar: Bavaro, Davide Fiore, Pizzutilo, Pamela, Catino, Annamaria, Signorile, Fabio, Pesola, Francesco, Di Gennaro, Francesco, Cassiano, Sandro, Marech, Ilaria, Lamorgese, Vito, Angarano, Gioacchino, Monno, Laura, Saracino, Annalisa, Galetta, Domenico
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2021
Konular:
Major Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204890/
https://ncbi.nlm.nih.gov/pubmed/34141817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab187
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller